Triazine compounds for treatment of CNS disorders
US6465461B1 · kind B1 · utility
1Cited by
5References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 2001 |
| Grant date | Oct 15, 2002 |
| Priority date | — |
| Expiry date | Jul 6, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D253/07
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (I) and pharmaceutically acceptable prodrugs, salts and solvates thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.